Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRestore Regulatory News (RST)

Share Price Information for Restore (RST)

Share Price is delayed by 15 minutes
Get Live Data
264.00    0.50 (0.19%)
Bid:
263.00
Ask:
265.00
Spread: 2.00 (0.76%)
Market Cap: £351.51m
RST Live PriceLast checked at - London Stock Exchange

Intraday Restore Share Chart

Offer Document Posted

2 Oct 2006 07:02

GE Fanuc Embedded Systems, Inc.02 October 2006 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY ORINDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE AVIOLATION OF THE RELEVANT LAWS IN THAT JURISDICTION FOR IMMEDIATE RELEASE 2 October 2006 RECOMMENDED CASH OFFER OF 410 PENCE PER SHARE FOR RADSTONE TECHNOLOGY PLC BY GE FANUC EMBEDDED SYSTEMS, INC. OFFER DOCUMENT POSTED Further to the announcement made on 18 September 2006 of a recommended cashoffer by GE Fanuc to acquire the entire issued and to be issued share capital ofRadstone, GE Fanuc announces that the offer document containing the full termsand conditions of the Offer dated 2 October 2006 (the "Offer Document") has beenposted to Radstone Shareholders today. If you hold Radstone Shares in certificated form, to accept the Offer, youshould complete, sign and return the Form of Acceptance, which accompanies yourOffer Document, in accordance with the instructions thereon and set out in theOffer Document as soon as possible and, in any event, so as to be received byCapita Registrars by no later than 3.00 p.m. (London time) on 23 October 2006. If you hold Radstone Shares in uncertificated form (that is, in CREST), toaccept the Offer you should accept the Offer electronically through CREST inaccordance with the instructions set out in the Offer Document so that the TTEInstruction settles by no later than 3.00 p.m. (London time) on 23 October 2006.If you hold Radstone Shares as a CREST sponsored member, you should refer toyour CREST sponsor as only your CREST sponsor will be able to send the necessaryTTE Instruction to CRESTCo. Copies of the Offer Document are available for inspection at the offices ofSlaughter and May, One Bunhill Row, London, EC1Y 8YY and will also be posted onGE Fanuc's website. Terms used in this announcement shall have the meaning given to them in theOffer Document. Enquiries: GE FanucMaryrose Sylvester (President and CEO) Tel: +1 434 978 5000Charles Alexander (President, GE Capital Europe) Tel: +44 (0)20 7302 6000 UBS Investment Bank (Financial adviser to GE Fanuc)Aidan Clegg Tel: +44 (0)20 7568 0000 Smithfield Financial (PR adviser to GE Fanuc)John Antcliffe Tel: +44 (0)20 7903 0665 RadstoneRhys Williams (Chairman) Tel: +44 (0)1327 359444Jeff Perrin (Chief Executive) Tel: +44 (0)1327 359444 Close Brothers (Financial adviser to Radstone)Andrew Cunningham Tel: +44 (0)20 7655 3100 JPMorgan Cazenove Limited (Corporate broker to Radstone)Julian Cazalet Tel: +44 (0)20 7588 2828 Buchanan Communications (PR adviser to Radstone)Tim Thompson Tel: +44 (0)20 7466 5000 UBS Investment Bank, which is authorised and regulated in the United Kingdom bythe Financial Services Authority, is acting exclusively for GE Fanuc and no oneelse in connection with the Offer and will not be responsible to anyone otherthan GE Fanuc for providing the protections afforded to its customers or forproviding advice in relation to the Offer, the contents of this announcement orany transaction or arrangement referred to herein. Close Brothers, which is authorised and regulated in the United Kingdom by theFinancial Services Authority, is acting exclusively as financial adviser forRadstone and no one else in connection with the Offer and will not beresponsible to anyone other than Radstone for providing the protections affordedto its customers or for providing advice in relation to the Offer, the contentsof this announcement or any transaction or arrangement referred to herein. JPMorgan Cazenove Limited, which is authorised and regulated in the UnitedKingdom by the Financial Services Authority, is acting exclusively as corporatebroker to Radstone and no one else in connection with the Offer and will not beresponsible to anyone other than Radstone for providing the protections affordedto its customers or for providing advice in relation to the Offer, the contentsof this announcement or any transaction or arrangement referred to herein. This announcement is not intended to and does not constitute, or form any partof, any offer to sell or any solicitation of any offer to purchase or subscribefor any securities or the solicitation of any vote or approval in anyjurisdiction. Any acceptance or other response to the Offer should be made onlyon the basis of the information contained or referred to in the Offer Documentand (in the case of holders of certificated Radstone shares only) the Form ofAcceptance. The availability of the Offer to persons who are not resident inthe United Kingdom may be affected by the laws of the relevant jurisdiction inwhich they are resident. Persons who are not resident in the United Kingdom, orwho are subject to the laws of any jurisdiction other than the United Kingdom,should inform themselves about the laws of such jurisdiction and observe anyapplicable requirements. The Offer will be made in the United States pursuantto an exemption from the US tender offer rules provided by the US Exchange Actand in Canada pursuant to certain exemptions from the takeover bid requirementscontained in applicable securities regulations. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
13th Mar 202512:24 pmRNSDirector/PDMR Shareholding
13th Mar 20257:00 amRNSFull year 2024 results
13th Mar 20257:00 amRNSAcquisition of Synertec (Holdings) Ltd
4th Mar 20258:04 amRNSHolding(s) in Company
4th Feb 20259:23 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSNotice of full year results
21st Nov 20247:00 amRNSTrading Update
7th Nov 20247:00 amRNSNotice of Trading Update
31st Oct 20241:07 pmRNSHolding(s) in Company
24th Oct 20247:00 amRNSAnalyst and Investor Site Visit
22nd Oct 20242:26 pmRNSDirector/PDMR Shareholding
17th Oct 20247:00 amRNSDirector/PDMR Shareholding
14th Oct 20247:00 amRNSBoard Change
2nd Sep 20247:00 amRNSDirector/PDMR Shareholding
23rd Aug 20249:21 amRNSDirector/PDMR Shareholding
16th Aug 202410:27 amRNSHolding(s) in Company
31st Jul 20247:00 amRNSHalf year results 2024
7th Jun 20247:49 amRNSHolding(s) in Company
3rd Jun 20241:17 pmRNSHolding(s) in Company
20th May 20242:03 pmRNSGrant of SAYE Options and PDMR Dealings
16th May 20244:29 pmRNSResult of Annual General Meeting
16th May 20247:00 amRNSTrading Update
12th Apr 20243:48 pmRNSHolding(s) in Company
5th Apr 20243:39 pmRNSDirector/PDMR Shareholding
25th Mar 20248:59 amRNSHolding(s) in Company
14th Mar 20247:00 amRNSFull year 2023 results
18th Jan 20247:00 amRNSTrading Update and Notice of Full Year Results
20th Dec 20237:00 amRNSHolding(s) in Company
18th Dec 202311:38 amRNSDirector/PDMR Shareholding
20th Nov 20234:07 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSTrading Update, Contract Award and CME
30th Oct 20237:00 amRNSBoard Changes
24th Oct 20233:33 pmRNSHolding(s) in Company
11th Oct 202312:07 pmRNSDirector/PDMR Shareholding
6th Oct 20233:52 pmRNSDirector/PDMR Shareholding
25th Sep 202310:55 amRNSDirector/PDMR Shareholding
22nd Sep 20234:43 pmRNSNotification of Major Holdings
12th Sep 20237:00 amRNSDirector/PDMR Shareholding
7th Sep 20237:00 amRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSBoard Changes
16th Aug 20237:00 amRNSInterim CFO Appointment
16th Aug 20237:00 amRNSHalf Year Results 2023
1st Aug 20233:23 pmRNSNotification of Major Holdings
19th Jul 20232:35 pmRNSNotification of Major Holdings
4th Jul 20237:01 amRNSBoard Changes
4th Jul 20237:00 amRNSTrading Update
22nd Jun 20236:08 pmRNSDirector/PDMR, Grant of LTIP
14th Jun 20237:00 amRNSBoard Change
24th May 20234:37 pmRNSNOTIFICATION OF MAJOR HOLDINGS
18th May 20233:42 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.